why choose us

First received: September 19, 2022

Clinical Trial: Use of Transcranial Photobiomodulation to Improve Cognition and Self-Reported Outcomes in Survivors of Childhood Cancer

Study Status: Completed

Recruit Status: RECRUITING

Condition: ALL

Study Type: INTERVENTIONAL


Official Title: Use of Transcranial Photobiomodulation to Improve Cognition and Self-Reported Outcomes in Survivors of Childhood Cancer

Brief Summary: Survivors of childhood cancer are at greater risk for long-term cognitive impairments that include attention, executive function, intelligence, memory, and processing speed.The participants are a survivor of acute lymphoblastic leukemia (ALL) or Hodgkin's lymphoma (HL).Because of your treatment the participant may have developed trouble with thinking and learning.Primary ObjectiveTo evaluate the feasibility of using home-based tPBM paired with remote cognitive training to improve cognitive performance in…

Read more